logo

Analyst Comments: Alcatel Lucent, Credit Suisse, Puget Energy, King Pharma, Safeco, Advanced Medical Optics, Mack-Cali
By: Zacks Investment Research   Tuesday, March 04, 2008 12:40 PM

Vote for next session
The next market session will close:

ALU to Trade at Historical Norm

Alcatel Lucent (ALU) reported stronger revenues for the fourth quarter of 2007, although its earnings were hit by a goodwill impairment charge of 2.5 billion ($3.65 billion) due to the perceived reduction in asset values of CDMA and IMS divisions. The company is proceeding on its restructuring plans by streamlining layers of management and it completed 6,700 job cuts.

We have increased our revenue estimates while maintaining our previously lowered earnings estimate for 2008 due to the continued pricing pressure and the geographic mix of growth as the company competes to win business in Asia based on price. We rate ALU a Hold with a target price of $6.10 per share or 10.7x our 2008 adjusted EPS estimate, which is closer to its historical norm.

Standard & Poor's has revised its rating outlook on the company to stable from positive which means that it is less likely to be raised in the next two years implying a higher cost of borrowing. We have increased our revenue estimates and we have maintained our previously lowered earnings estimates for 2008 due to the continued pricing pressure and the geographic mix of growth as the company competes to win business in Asia based on price. Despite the negatives which also include possibility of a consumer-driven recession in the U.S., we believe the shares have incorporated all the negatives surrounding the company and the industry.

Udayan Mukherjee contributed to this report.

Fair Value $50 for Credit Suisse

We are continuing our Hold on Credit Suisse Group (or
CSG) (CS), but reducing our target price to $50. CSG posted fourth quarter earnings of CHF1,329 million, down 49% year over year. This reflected CHF1.3 billion in writedowns at the investment banking group in structured products and leveraged loan commitments related to credit market turmoil, as well as CHF774 million in valuation reductions at asset management.

Also, we are cutting our 2008 EPADS estimates to $5.85 from $7.18. We expect results to continue to reflect problems stemming from weakness in the subprime mortgage and other credit markets. CSG has repurchased CHF4.1 billion under a CHF8 billion share repurchase program and just increased the dividend by 12%.

At its current stock price, Credit Suisse trades at substantial discounts to the industry median, based on 2008 and 2009 consensus estimated earnings and price/book. The 3-5 year outlook for CSG's earnings growth is 10% versus 12% for the industry, while CSG's dividend yield of 4.9% is above average.


Next Page >>123

(0)
No Comments
Post Comment
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
   
 
 
 
 
   
 

The above story is the opinion of the author only and it does not reflect iStockAnalyst opinion. Further, the author is not personally advising you regarding the suitability of the story for your investment needs. In no event iStockAnalyst will be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from or arising out of, or in connection with the use of this information. Please consult your investment advisor before making any investment decision.
  
Advertisement
Popular Articles
Related Press Releases
Advertisement
Partner Center
Recent Articles by Zacks Investment Research



Subscribe to Email Alerts rss feed or RSS feeds rss feed for articles from more than 500 contributors, press releases, SEC filings and full text news from more than four thousand sources.
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia